Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Lab Partners is a private U.S. healthcare consultancy and molecular diagnostics services company focused on helping physician practices and high-complexity laboratories launch or expand in-house PCR testing. The company offers end-to-end implementation support spanning licensing, staffing, validation, operational setup, and concierge backend support, alongside ready-to-run custom plated assays in tube, strip tube, and pre-plated formats. Its offering is positioned around operationally streamlined molecular testing rather than drug development, with current panels centered on respiratory pathogens and urinary tract infection testing and additional panels in development. Molecular Lab Partners also partnered with Dendi in 2025 to combine laboratory implementation services with cloud-native LIS capabilities for physician office labs, urgent care centers, and multi-site laboratory networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Lab Partners.